Management notified in question time at the last annual general meeting that INV103 would only be progressed to the second level of dosing in patients with slightly more active condition. The higher doses they advised would have to be done with a partner
- Forums
- ASX - By Stock
- IVX
- Ann: PhII smoking cessation - dosing complete analysis underway
IVX
invion limited
Add to My Watchlist
0.00%
!
9.6¢

Ann: PhII smoking cessation - dosing complete analysis underway, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.199M |
Open | High | Low | Value | Volume |
9.6¢ | 9.8¢ | 9.6¢ | $3.656K | 38.07K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20756 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 146502 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20756 | 0.096 |
3 | 46032 | 0.095 |
1 | 47000 | 0.094 |
2 | 33000 | 0.093 |
1 | 42667 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 146502 | 2 |
0.100 | 178594 | 3 |
0.105 | 38013 | 4 |
0.110 | 28153 | 1 |
0.115 | 65728 | 3 |
Last trade - 15.11pm 07/08/2025 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |